BioCentury
ARTICLE | Distillery Therapeutics

Neurology

August 16, 2018 4:10 PM UTC

Mouse studies suggest optogenetically activating or agonizing 5-HT1B receptors on neurons projecting from the dorsal raphe to the nucleus accumbens could help treat autism spectrum disorders (ASDs) ca...